Amer Bio Medica (ABMC)

OTC Markets
0.037
0.000(0.00%)
  • Volume:
    20,815
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    0.035 - 0.037

ABMC Overview

Prev. Close
0.037
Day's Range
0.035-0.037
Revenue
2.76M
Open
0.035
52 wk Range
0.032-0.319
EPS
-0.03
Volume
20,815
Market Cap
1.65M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
208,920
P/E Ratio
-
Beta
-1.95
1-Year Change
-71.54%
Shares Outstanding
44,698,476
Next Earnings Date
Nov 17, 2021
What is your sentiment on Amer Bio Medica?
or
Market is currently closed. Voting is open during market hours.

Amer Bio Medica News

  • American Bio Medica reports Q2 results
    • BySeeking Alpha-

    American Bio Medica (OTCPK:ABMC): Q2 EPS of $0.00Revenue of $1.31M (-13.2% Y/Y)Press ReleaseNow read: Repros Therapeutics reports Q2 resultsOriginal article

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralNeutralNeutralStrong SellStrong Sell
Technical IndicatorsSellSellSellStrong SellStrong Sell
SummaryNeutralNeutralNeutralStrong SellStrong Sell

Amer Bio Medica Company Profile

Amer Bio Medica Company Profile

Employees
79

American Bio Medica Corporation develops, manufactures and sells immunoassay tests, primarily for the immediate, point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. The Company's DOA POCT products offer employers, law enforcement, government, healthcare and education professionals to identify illicit drug use. In addition to the manufacture and sale of DOA POCT products, the Company provides bulk test strip manufacturing services to unaffiliated third parties on a contract basis. Its Rapid Drug Screen (RDS) is a POCT product that detects the presence or absence of 2 to 10 DOA simultaneously in a single urine specimen. The Rapid ONE product line consists of single drug tests, each of which tests for the presence or absence of a single drug of abuse in a urine specimen. The RDS InCup is a POCT product that detects the presence or absence of 1 to 12 DOA in a single urine specimen. The POCT products for oral fluid-based DOA testing include OralStat.

Read More
  • Bought 40k @$.09
    0
    • fiya
      0
      Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
      Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.